Australian trial of mitochondrial treatments for chronic fatigue syndrome

by Sasha Nimmo Melbourne scientists are testing a combination of mitochondrial supplements on 8 or 9 patients with chronic fatigue syndrome (Fukuda criteria). The 20-week study for patients with Fukuda chronic fatigue syndrome is open-label, so patients are aware they are receiving the treatment and there is no placebo group.  Participants take the capsules daily, as well as medical … Continue reading Australian trial of mitochondrial treatments for chronic fatigue syndrome